Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Augmenting Atropine Treatment for Amblyopia
NCT00944710Phase 3Completed
- Sponsor
- Jaeb Center for Health Research
- Start
- Aug 2009
- Primary completion
- Oct 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atropine in amblyopia, sponsored by Jaeb Center for Health Research. Started Aug 2009; status: completed.
02
Drugs
atropine
03
Conditions
amblyopia
Beyond the preview
Go deeper on NCT00944710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944710.